Found 5 matching trials
A Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Initial Efficacy of JS212 in Subjects With Advanced Malignant Solid Tumour PHASE1 This study is a Phase I/II Clinical Study to Evaluate the Safety, Tolerabil...
Show More Location
Shanghai Chest Hospital
Learn More & Join Trial
A Phase II Clinical Study Evaluating the Combination Therapy of JS212 in Patients With Advanced Lung Cancer PHASE2 This is a multicenter, open-label Phase II clinical study, with the main ob...
Show More Location
Shanghai East Hospital
Learn More & Join Trial
JS212 Plus JS111 in EGFR-Mutant Advanced NSCLC: A Phase II Study PHASE2 This is a Phase II study evaluating the safety, tolerability, pharmacokinet...
Show More Location
Shanghai Chest Hospital
Learn More & Join Trial
JS212 in Combination With JS111 as First-Line Treatment in EGFR-Mutant Advanced NSCLC NA This is a single-arm clinical study evaluating the safety, tolerability, an...
Show More Location
The First Affiliated Hospital of Anhui Medical University
Learn More & Join Trial
Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors PHASE2 This is a multicenter, open-label Phase II clinical study. The primary obje...
Show More Location
Peking University Cancer Hospital
Learn More & Join Trial